TG Therapeutics Stock Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
A buy signal generated when short-term moving averages cross long-term moving averages in an upward direction.
Sell Signal (MA)
A sell signal generated when short-term moving averages cross long-term moving averages in a downward direction.
Stock Analysis |
|
Risk Assessment |
|
Trading Strategy |
|
Green day on Thursday for TG Therapeutics stock after gaining 0.119%
(Updated on Sep 19, 2024)
Buy or Hold candidate since Aug 06, 2024
Gain 22.84%
The TG Therapeutics stock price gained 0.119% on the last trading day (Thursday, 19th Sep 2024), rising from $25.25 to $25.28. It has now gained 6 days in a row. It is not often that stock manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.01% from a day low at $25.09 to a day high of $26.09. The price has risen in 8 of the last 10 days and is up by 17.8% over the past 2 weeks. Volume fell on the last day by -450 thousand shares and in total, 4 million shares were bought and sold for approximately $96.46 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 30.47% during the next 3 months and, with a 90% probability hold a price between $26.70 and $35.78 at the end of this 3-month period.
TGTX Signals & Forecast
The TG Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $24.36 and $22.52. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, September 05, 2024, and so far it has risen 17.80%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for TG Therapeutics stock
TG Therapeutics finds support from accumulated volume at $25.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.01 between high and low, or 4.01%. For the last week, the stock has had daily average volatility of 5.66%.
Since the TG Therapeutics has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.
Our recommended stop-loss: $24.13 (-4.55%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 22 days ago.)
Trading Expectations (TGTX) For The Upcoming Trading Day Of Friday 20th
For the upcoming trading day on Friday, 20th we expect TG Therapeutics to open at $25.49, and during the day (based on 14 day Average True Range), to move between $23.92 and $26.64, which gives a possible trading interval of +/-$1.36 (+/-5.38%) up or down from last closing price. If TG Therapeutics takes out the full calculated possible swing range there will be an estimated 10.76% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $25.19, some $0.0900 (0.36%) from the current price of $25.28, our system finds the risk reward attractive.
Is TG Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for TG Therapeutics stock to perform well in the short-term.
Current score: 3.002 Buy Candidate Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on September 20, 2024 - $25.49 ( 0.81%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for TGTX
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 26.49 | 4.79% |
R2 | 26.11 | 3.27% |
R1 | 25.87 | 2.33% |
Price | 25.28 | |
S1 | 25.10 | -0.708% |
S2 | 24.86 | -1.65% |
S3 | 24.48 | -3.16% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 0 | - |
R2 | 0 | - |
R1 | 0 | - |
Price | 25.28 | |
S1 | 25.19 | -0.356% |
S2 | 22.08 | -12.66% |
S3 | 20.58 | -18.59% |
FAQ
Click here for our free guide on how to buy TG Therapeutics Stock.